1. Home
  2. LINC vs TRML Comparison

LINC vs TRML Comparison

Compare LINC & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LINC
  • TRML
  • Stock Information
  • Founded
  • LINC 1946
  • TRML 2021
  • Country
  • LINC United States
  • TRML United States
  • Employees
  • LINC N/A
  • TRML N/A
  • Industry
  • LINC Other Consumer Services
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • LINC Real Estate
  • TRML Health Care
  • Exchange
  • LINC Nasdaq
  • TRML Nasdaq
  • Market Cap
  • LINC 499.3M
  • TRML 509.8M
  • IPO Year
  • LINC 2005
  • TRML N/A
  • Fundamental
  • Price
  • LINC $16.20
  • TRML $17.88
  • Analyst Decision
  • LINC Strong Buy
  • TRML Strong Buy
  • Analyst Count
  • LINC 4
  • TRML 6
  • Target Price
  • LINC $18.00
  • TRML $54.00
  • AVG Volume (30 Days)
  • LINC 170.1K
  • TRML 224.3K
  • Earning Date
  • LINC 02-24-2025
  • TRML 03-18-2025
  • Dividend Yield
  • LINC N/A
  • TRML N/A
  • EPS Growth
  • LINC N/A
  • TRML N/A
  • EPS
  • LINC 0.32
  • TRML N/A
  • Revenue
  • LINC $423,213,000.00
  • TRML N/A
  • Revenue This Year
  • LINC $16.43
  • TRML N/A
  • Revenue Next Year
  • LINC $8.66
  • TRML N/A
  • P/E Ratio
  • LINC $50.43
  • TRML N/A
  • Revenue Growth
  • LINC 15.21
  • TRML N/A
  • 52 Week Low
  • LINC $8.91
  • TRML $12.12
  • 52 Week High
  • LINC $18.74
  • TRML $48.31
  • Technical
  • Relative Strength Index (RSI)
  • LINC 59.69
  • TRML 33.31
  • Support Level
  • LINC $14.31
  • TRML $17.00
  • Resistance Level
  • LINC $15.54
  • TRML $20.08
  • Average True Range (ATR)
  • LINC 0.52
  • TRML 1.24
  • MACD
  • LINC 0.09
  • TRML -0.15
  • Stochastic Oscillator
  • LINC 98.44
  • TRML 16.89

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services and business and information technology. Its reportable segments include; Campus Operations, and Transitional. Majority of the revenue is generated from Campus Operations segment which includes all campuses that are continuing in operation and contribute to the Company's core operations and performance.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: